title: German drug companies are criticised for not focusing on useful therapeutic areas.
authors.affiliation: Hamburg.
authors.forename: Ned
authors.initials: N
authors.lastname: Stafford
mesh_terms: D003363:Cost Control; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D004358:Drug Therapy / Q000191:economics; D005858:Germany; D006801:Humans; D035583:Rare Diseases / Q000188:drug therapy